UNSPSC 51293614: Pirlindole hydrochloride

This classification denotes a monoamine oxidase inhibitor C15H18N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q89W8I397C, chemically known as 1h-pyrazino(3,2,1-jk)carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl-, hydrochloride (1:1), but more generally known as pirlindole hydrochloride, which bears US NIH Compound Identifier 115141. European Medicines Agency schedules Pirlindole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35547.

Most nations, for tariff and trade purposes, schedule pirlindole hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, PIRLINDOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CCC2C(C1)C3C4N2CCNC4CCC3.CL.

UNSPSC 51293614 Pirlindole hydrochloride is a Commodity code for a specific antidepressant pharmaceutical agent, but the recent state and local procurement activity tagged under this code does not align with its nominal scope. Seminole County, Florida's recent IFB solicitation (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) sought procurement of naloxone and safe drug deactivation systems — opioid antagonists and harm-reduction equipment with no pharmaceutical relationship to pirlindole. This mismatch suggests either a coding error in the source data or a broad misclassification of the opportunity in the posting system. The code shows no evidence of active state and local procurement for pirlindole hydrochloride itself.

The Seminole County opportunity, while tagged to this code, represents demand for emergency-response and public-health commodities rather than psychiatric pharmaceuticals. No additional recent opportunities under UNSPSC 51293614 appear in the source block. Given the disconnect between the code's intended scope and the single opportunity on record, this code does not present a reliable procurement signal for business development planning purposes at this time.